Our findings suggest the possibility that genetic variants of CYP19A1 (rs1004982, rs16964228, and rs1902580) might be involved in altering estrogen levels and affecting apoptosis, mucosal function, carcinogenesis, and thus gastric cancer risk. The gene discussed is CYP19A1; the disease is gastric cancer.